1. Home
  2. ICHR vs ELVN Comparison

ICHR vs ELVN Comparison

Compare ICHR & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ichor Holdings

ICHR

Ichor Holdings

HOLD

Current Price

$18.42

Market Cap

605.5M

Sector

Technology

ML Signal

HOLD

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

HOLD

Current Price

$15.43

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICHR
ELVN
Founded
1999
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
605.5M
1.1B
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
ICHR
ELVN
Price
$18.42
$15.43
Analyst Decision
Buy
Strong Buy
Analyst Count
5
4
Target Price
$26.50
$41.00
AVG Volume (30 Days)
544.3K
796.1K
Earning Date
02-03-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$957,337,000.00
N/A
Revenue This Year
$13.48
N/A
Revenue Next Year
$5.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.86
N/A
52 Week Low
$13.12
$13.30
52 Week High
$35.56
$25.37

Technical Indicators

Market Signals
Indicator
ICHR
ELVN
Relative Strength Index (RSI) 54.92 35.13
Support Level $18.32 $15.88
Resistance Level $19.37 $18.05
Average True Range (ATR) 0.70 1.13
MACD 0.13 -0.16
Stochastic Oscillator 66.73 9.68

Price Performance

Historical Comparison
ICHR
ELVN

About ICHR Ichor Holdings

Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, Singapore, Europe, and Others, of which a majority of the revenue is generated from Singapore.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: